Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 2, 2014.

Or

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                         

Commission file number   1-6357

 

LOGO

ESTERLINE TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

 

  Delaware   13-2595091  
 

(State or other Jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

500 108th Avenue N.E., Bellevue, Washington 98004

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code (425) 453-9400

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer   þ         Accelerated filer   ¨         Non-accelerated filer   ¨         Smaller reporting company   ¨

  (Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  þ

As of June 2, 2014, 31,970,428 shares of the issuer’s common stock were outstanding.


PART I – FINANCIAL INFORMATION

Item 1.                     Financial Statements

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of May 2, 2014 and October 25, 2013

(In thousands, except share amounts)

 

                                                       
     May 2,
2014
    October 25,
2013
 

ASSETS

     (Unaudited)     

Current Assets

    

Cash and cash equivalents

   $ 207,443      $ 179,178   

Cash in escrow

     0        4,018   

Accounts receivable, net of allowances
of $9,915 and $9,215

     354,937        383,666   

Inventories

    

Raw materials and purchased parts

     178,202        165,231   

Work in process

     204,286        182,882   

Finished goods

     106,742        99,550   
  

 

 

   

 

 

 
     489,230        447,663   

Income tax refundable

     7,481        6,526   

Deferred income tax benefits

     47,100        47,277   

Prepaid expenses

     26,917        18,183   

Other current assets

     5,716        5,204   
  

 

 

   

 

 

 

Total Current Assets

     1,138,824        1,091,715   

Property, Plant and Equipment

     784,380        767,861   

Accumulated depreciation

     418,137        396,664   
  

 

 

   

 

 

 
     366,243        371,197   

Other Non-Current Assets

    

Goodwill

     1,143,226        1,128,977   

Intangibles, net

     581,393        580,949   

Debt issuance costs, net of accumulated
amortization of $5,211 and $4,359

     5,359        6,211   

Deferred income tax benefits

     71,330        71,840   

Other assets

     19,039        11,223   
  

 

 

   

 

 

 
   $ 3,325,414      $ 3,262,112   
  

 

 

   

 

 

 

 

2


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of May 2, 2014 and October 25, 2013

(In thousands, except share amounts)

 

                                                       
     May 2,
2014
    October 25,
2013
 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     (Unaudited)     

Current Liabilities

    

Accounts payable

   $ 118,826      $ 123,597   

Accrued liabilities

     242,615        253,561   

Current maturities of long-term debt

     17,980        21,279   

Deferred income tax liabilities

     2,727        2,307   

Federal and foreign income taxes

     6,012        7,348   
  

 

 

   

 

 

 

Total Current Liabilities

     388,160        408,092   

Long-Term Liabilities

    

Credit facilities

     130,000        130,000   

Long-term debt, net of current maturities

     519,254        537,859   

Deferred income tax liabilities

     184,842        193,119   

Pension and post-retirement obligations

     63,750        68,102   

Other liabilities

     49,431        40,188   

Shareholders’ Equity

    

Common stock, par value $.20 per share,
authorized 60,000,000 shares, issued and
outstanding 31,941,378 and 31,441,949

     6,388        6,288   

Additional paid-in capital

     639,313        604,511   

Retained earnings

     1,352,072        1,285,090   

Accumulated other comprehensive loss

     (19,583     (22,284
  

 

 

   

 

 

 

Total Esterline shareholders’ equity

     1,978,190        1,873,605   

Noncontrolling interests

     11,787        11,147   
  

 

 

   

 

 

 

Total Shareholders’ Equity

     1,989,977        1,884,752   
  

 

 

   

 

 

 
   $ 3,325,414      $ 3,262,112   
  

 

 

   

 

 

 

 

3


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS

AND COMPREHENSIVE INCOME

For the Three and Six Month Periods Ended May 2, 2014 and April 26, 2013

(Unaudited)

(In thousands, except per share amounts)

 

     Three Months Ended     Six Months Ended  
     May 2,
2014
    April 26,
2013
    May 2,
2014
    April 26,
2013
 

Net Sales

   $        529,574      $        499,562      $     1,034,554      $        957,524   

Cost of Sales

     347,229        318,186        678,914        615,803   
  

 

 

   

 

 

   

 

 

   

 

 

 
     182,345        181,376        355,640        341,721   

Expenses

        

Selling, general & administrative

     98,470        98,278        194,676        196,889   

Research, development & engineering

     26,801        25,658        53,307        48,734   

Restructuring charges

     2,078        0        6,874        0   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Expenses

     127,349        123,936        254,857        245,623   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Earnings From Continuing Operations

     54,996        57,440        100,783        96,098   

Interest Income

     (137     (148     (257     (249

Interest Expense

     8,439        11,482        17,069        21,926   

Loss on Extinguishment of Debt

     0        946        0        946   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings From Continuing Operations

Before Income Taxes

     46,694        45,160        83,971        73,475   

Income Tax Expense

     9,150        9,482        16,263        11,876   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings From Continuing Operations

Including Noncontrolling Interests

     37,544        35,678        67,708        61,599   

Earnings Attributable to

Noncontrolling Interests

     (297     (156     (383     (966
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings From Continuing Operations

Attributable to Esterline, Net of Tax

     37,247        35,522        67,325        60,633   

Loss From Discontinued Operations

Attributable to Esterline, Net of Tax

     (343     0        (343     0   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Earnings Attributable to Esterline

   $ 36,904      $ 35,522      $ 66,982      $ 60,633   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (Loss) Per Share Attributable to Esterline – Basic:

  

     

Continuing operations

   $ 1.17      $ 1.14      $ 2.12      $ 1.96   

Discontinued operations

     (.01     .00        (.01     .00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (Loss) Per Share Attributable
to Esterline – Basic

   $ 1.16      $ 1.14      $ 2.11      $ 1.96   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (Loss) Per Share Attributable to Esterline – Diluted:

        

Continuing operations

   $ 1.15      $ 1.12      $ 2.08      $ 1.92   

Discontinued operations

     (.01     .00        (.01     .00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (Loss) Per Share Attributable
to Esterline – Diluted

   $ 1.14      $ 1.12      $ 2.07      $ 1.92   
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive Income

   $ 80,121      $ 1,367      $ 69,683      $ 38,258   

 

4


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

For the Six Month Periods Ended May 2, 2014 and April 26, 2013

(Unaudited)

(In thousands)

 

                                                 
     Six Months Ended  
     May 2,
2014
    April 26,
2013
 

Cash Flows Provided (Used) by Operating Activities

    

Net earnings including noncontrolling interests

   $ 67,365      $ 61,599   

Adjustments to reconcile net earnings including noncontrolling
interests to net cash provided (used) by operating activities:

    

Depreciation and amortization

     59,282        56,288   

Deferred income taxes

     (8,410     (5,676

Share-based compensation

     6,648        5,658   

Gain on sale of capital assets

     0        (695

Working capital changes, net of effect of acquisitions:

    

Accounts receivable

     33,331        41,591   

Inventories

     (33,485     (18,279

Prepaid expenses

     (8,072     (1,974

Other current assets

     (276     (281

Accounts payable

     (10,650     422   

Accrued liabilities

     (13,224     (13,587

Federal and foreign income taxes

     (3,754     (2,808

Other liabilities

     (1,587     (3,212

Other, net

     (2,716     3,638   
  

 

 

   

 

 

 
     84,452        122,684   

Cash Flows Provided (Used) by Investing Activities

    

Purchases of capital assets

     (21,297     (25,085

Proceeds from sale of capital assets

     0        695   

Acquisitions of business, net of cash acquired

     (44,043     (40,689
  

 

 

   

 

 

 
     (65,340     (65,079

Cash Flows Provided (Used) by Financing Activities

    

Proceeds provided by stock issuance under employee
stock plans

     22,957        15,201   

Excess tax benefits from stock options exercises

     5,297        1,820   

Repayment of long-term credit facilities

     (25,000     (40,000

Repayment of long-term debt

     (19,302                 (197,458

Proceeds from issuance of long-term credit facilities

     25,000        175,000   

Dividends paid to noncontrolling interests

     (780     (962

Debt and other issuance costs

     0        (453
  

 

 

   

 

 

 
     8,172        (46,852

Effect of Foreign Exchange Rates on Cash and Cash Equivalents

     981        (2,251
  

 

 

   

 

 

 

Net Increase (Decrease) in Cash and Cash Equivalents

     28,265        8,502   

Cash and Cash Equivalents – Beginning of Period

     179,178        160,675   
  

 

 

   

 

 

 

Cash and Cash Equivalents – End of Period

   $              207,443      $ 169,177   
  

 

 

   

 

 

 

Supplemental Cash Flow Information

    

Cash paid for interest

   $ 14,688      $ 21,906   

Cash paid for taxes

     29,724        20,984   

 

5


ESTERLINE TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three and Six Month Periods Ended May 2, 2014 and April 26, 2013

 

1. The consolidated balance sheet as of May 2, 2014, the consolidated statement of operations and comprehensive income for the three and six month periods ended May 2, 2014, and April 26, 2013, and the consolidated statement of cash flows for the six month periods ended May 2, 2014, and April 26, 2013, are unaudited but, in the opinion of management, all of the necessary adjustments, consisting of normal recurring accruals, have been made to present fairly the financial statements referred to above in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the above statements do not include all of the footnotes required for complete financial statements. The results of operations and cash flows for the interim periods presented are not necessarily indicative of results that can be expected for the full year.

 

2. The notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended October 25, 2013, provide a summary of significant accounting policies and additional financial information that should be read in conjunction with this Form 10-Q.

 

3. The timing of the Company’s revenues is impacted by the purchasing patterns of customers and, as a result, revenues are not generated evenly throughout the year. Moreover, the Company’s first fiscal quarter, November through January, includes significant holiday periods in both Europe and North America. The first six months of fiscal 2014 contained 27 weeks, while the first six months of fiscal 2013 contained 26 weeks.

 

4. Basic earnings per share is computed on the basis of the weighted average number of shares outstanding during the year. Diluted earnings per share includes the dilutive effect of stock options and restricted stock units. Common shares issuable from stock options that were excluded from the calculation of diluted earnings per share because they were anti-dilutive were 177,100 and 249,900 in the second fiscal quarter of 2014 and 2013, respectively. Shares used for calculating earnings per share are disclosed in the following table.

 

(In thousands)   Three Months Ended     Six Months Ended  
    May 2,
        2014        
    April 26,
        2013        
    May 2,
        2014        
    April 26,
        2013        
 

Shares Used for Basic Earnings Per Share

    31,867        31,100        31,733        31,002   

Shares Used for Diluted Earnings Per Share

    32,475        31,696        32,348        31,559   

 

5. The Company’s comprehensive income is as follows:

 

(In thousands)   Three Months Ended     Six Months Ended  
    May 2,
        2014        
    April 26,
        2013        
    May 2,
        2014        
    April 26,
        2013        
 

Net Earnings

  $ 36,904      $ 35,522      $ 66,982      $ 60,633   

Change in Fair Value of Derivative

Financial Instruments, Net of Tax (1)

    4,963        (1,540     (3,960     (1,586

Change in Pension and Post-retirement

Obligations, Net of Tax (2)

    254        2,126        2,146        1,975   

Foreign Currency Translation Adjustment

    38,000        (34,741     4,515        (22,764
 

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive Income

  $ 80,121      $ 1,367      $ 69,683      $ 38,258   
 

 

 

   

 

 

   

 

 

   

 

 

 

 

  (1)  Net of tax benefit (expense) of $(1,828) and $705 for the second fiscal quarter of 2014 and 2013, respectively. Net of tax benefit of $1,516 and $481 for the first six months of fiscal 2014 and 2013, respectively.

 

  (2)  Net of tax expense of $(214) and $(1,130) for the second fiscal quarter of 2014 and 2013, respectively. Net of tax expense of $(1,016) and $(1,075) for the first six months of fiscal 2014 and 2013, respectively.

 

6


The Company’s accumulated other comprehensive loss is comprised of the following:

 

(In thousands)    May 2,
          2014          
           October 25,
          2013          
 

Net unrealized loss on derivative contracts

   $ (5,456     $ (1,496

Pension and post-retirement obligations

     (54,039       (56,185

Currency translation adjustment

     39,912          35,397   
  

 

 

     

 

 

 

Total accumulated other comprehensive loss

   $ (19,583     $ (22,284
  

 

 

     

 

 

 

 

6. On December 20, 2013, the Company acquired Sunbank Family of Companies, LLC (Sunbank) for $51.0 million. The purchase price included $5 million in additional contingent consideration based upon achievement of certain sales levels over a two-year period. Sunbank is a manufacturer of electrical cable accessories, connectors and flexible conduit systems. Sunbank is included in the Sensors & Systems segment.

On February 4, 2013, the Company acquired the Gamesman Group (Gamesman) for $40.8 million. Gamesman is a global supplier of input devices principally serving the gaming industry. Gamesman is included in the Avionics & Controls segment.

 

7. During the second fiscal quarter of 2014, management performed an impairment test of Eclipse Electronic Systems, Inc.’s (Eclipse) long-lived assets including property, plant and equipment and intangible assets due to the uncertain outlook for sales and earnings over the next five years. The net book value of Eclipse’s long-lived assets at May 2, 2014, totaled $41.5 million. Although Eclipse’s sales are currently being delayed and orders pushed out, the forecast of undiscounted cash flow over the remaining useful life of the intangible assets exceeded the book value of Eclipse, and accordingly, no impairment was recorded.

 

8. The income tax rate was 19.4% and 16.2% for the first six months of fiscal 2014 and 2013, respectively. In the first six months of fiscal 2014, the Company recognized approximately $1.1 million of discrete tax benefits principally related to the following items. The first item was approximately $0.6 million of tax benefits due to the release of reserves due to the expiration of a statute of limitations. The second item was a $0.5 million reduction of net deferred income tax liabilities as a result of the enactment of tax laws reducing the U.K. statutory income tax rate. In the first six months of fiscal 2013, the Company recognized $3.6 million of discrete tax benefits principally related to the following items. The first item was approximately $1.5 million of tax benefits due to the retroactive extension of the U.S. federal research and experimentation credits. The second item was approximately $2.3 million of tax benefits related to the settlement of U.S. and foreign tax examinations. The income tax rate differed from the statutory rate in the first six months of fiscal 2014 and 2013, as both years benefited from various tax credits and certain foreign interest expense deductions.

It is reasonably possible that within the next twelve months approximately $1.6 million of tax benefits that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of a statute of limitations.

 

9. As of May 2, 2014, the Company had three share-based compensation plans, which are described below. The compensation cost that has been charged against income for those plans for the first six months of fiscal 2014 and 2013 was $6.6 million and $5.7 million, respectively. During the first six months of fiscal 2014 and 2013, the Company issued 491,320 and 383,669 shares, respectively, under its share-based compensation plans.

Employee Stock Purchase Plan (ESPP)

The ESPP is a “safe-harbor” designed plan whereby shares are purchased by participants at a discount of 5% of the market value on the purchase date and, therefore, compensation cost is not recorded.

Employee Sharesave Scheme

The Company offers shares under its employee sharesave scheme for U.K. employees. This plan allows participants the option to purchase shares at a discount of 5% of the market price of the stock as of the beginning of the offering period. The term of these options is three years. The sharesave scheme is not a “safe-harbor” design, and therefore, compensation cost is recognized on this plan. Under the sharesave scheme,

 

7


option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant. The Company granted 29,242 and 16,722 options in the six month periods ended May 2, 2014, and April 26, 2013, respectively. The weighted-average grant date fair value of options granted during the six month periods ended May 2, 2014, and April 26, 2013, was $27.03 and $20.24 per share, respectively.

The fair value of the awards under the employee sharesave scheme was estimated using a Black-Scholes pricing model which uses the assumptions noted in the following table. The risk-free rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of grant.

 

     Six Months Ended  
     May 2,
          2014          
     April 26,
          2013          
 

Volatility

     33.69%         36.97%   

Risk-free interest rate

     0.73%         0.40%   

Expected life (years)

     3            3      

Dividends

     0            0      

Equity Incentive Plan

Under the equity incentive plan, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant. The Company granted 191,900 and 237,700 options in the six month periods ended May 2, 2014, and April 26, 2013, respectively. The weighted-average grant date fair value of options granted during the six month periods ended May 2, 2014, and April 26, 2013, was $45.20 and $29.12 per share, respectively.

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model which uses the assumptions noted in the following table. The Company uses historical data to estimate volatility of the Company’s common stock and option exercise and employee termination assumptions. The risk-free rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of the grant.

 

     Six Months Ended  
     May 2,
          2014          
     April 26,
          2013          
 

Volatility

     41.87 – 43.17%         41.89 – 44.25%   

Risk-free interest rate

     1.73 – 2.99%         0.79 – 1.88%   

Expected life (years)

     5 – 9            4.5 – 9.5      

Dividends

     0            0      

The Company granted 77,075 and 32,200 restricted stock units in the six month periods ended May 2, 2014, and April 26, 2013, respectively. The weighted-average grant date fair value of restricted stock units granted during the six month periods ended May 2, 2014, and April 26, 2013, was $84.34 and $62.52 per share, respectively. The fair value of each restricted stock unit granted by the Company is equal to the fair market value of the Company’s common stock on the date of grant.

 

8


10. The Company’s pension plans principally include a U.S. pension plan maintained by Esterline and a non-U.S. plan maintained by CMC Electronics, Inc. (CMC). Components of periodic pension cost consisted of the following:

 

(In thousands)          Three Months Ended              Six Months Ended      
             May 2,      
2014
         April 26,    
2013
           May 2,      
2014
         April 26,    
2013
 

Service cost

     $ 2,894       $ 2,974       $ 5,623       $ 6,271   

Interest cost

       4,765         4,382         9,577         8,794   

Expected return on plan assets

       (6,939      (5,632      (13,451      (11,305

Amortization of prior service cost

       19         21         38         42   

Amortization of actuarial loss

       1,343         3,443         2,700         6,855   
    

 

 

    

 

 

    

 

 

    

 

 

 

Net Periodic Cost

     $ 2,082       $ 5,188       $ 4,487       $ 10,657   
    

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s principal post-retirement plans include non-U.S. plans, which are non-contributory healthcare and life insurance plans. The components of expense of these other retirement benefits consisted of the following:

 

   

(In thousands)          Three Months Ended              Six Months Ended      
             May 2,      
2014
         April 26,    
2013
           May 2,      
2014
         April 26,    
2013
 

Service cost

     $ 228       $ 254       $ 463       $ 513   

Interest cost

       184         186         373         376   

Amortization of prior service cost

       (17      (17      (34      (34

Amortization of actuarial loss (gain)

       (66      8         (134      16   
    

 

 

    

 

 

    

 

 

    

 

 

 

Net Periodic Cost

     $ 329       $ 431       $ 668       $ 871   
    

 

 

    

 

 

    

 

 

    

 

 

 

 

11. In March 2011, the Company entered into a secured credit facility for $460 million made available through a group of banks. The credit facility is secured by substantially all of the Company’s assets and interest is based on standard inter-bank offering rates. The credit facility expires in July 2016. The interest rate ranges from LIBOR plus 1.5% to LIBOR plus 2.25% depending on the leverage ratios at the time the funds are drawn. At May 2, 2014, the Company had $130.0 million outstanding under the secured credit facility at an interest rate of LIBOR plus 1.75%, which was 1.91% at May 2, 2014.

In July 2011, the Company amended the secured credit facility to provide for a €125.0 million term loan (Euro Term Loan). The interest rate on the Euro Term Loan ranges from Euro LIBOR plus 1.5% to Euro LIBOR plus 2.25% depending on the leverage ratios at the time the funds are drawn. At May 2, 2014, the Company had €9.0 million outstanding or $12.5 million under the Euro Term Loan at an interest rate of Euro LIBOR plus 1.75%, which was 2.00% at May 2, 2014. The loan amortizes at 1.25% of the original principal balance quarterly through March 2016, with the remaining balance due in July 2016.

In April 2013, the Company amended the secured credit facility to include a $175.0 million term loan (U.S. Term Loan). The interest rate on the U.S. Term Loan ranges from LIBOR plus 1.5% to LIBOR plus 2.25% depending on the leverage ratios at the time the funds are drawn. At May 2, 2014, the Company had $166.3 million outstanding under the U.S. Term Loan at an interest rate of LIBOR plus 1.75%, which was 1.91% at May 2, 2014. The loan amortizes at 1.25% of the original principal balance quarterly through March 2016, with the remaining balance due in July 2016.

In April 2013, the Company redeemed the $175.0 million 6.625% Senior Notes due March 2017 (2017 Notes). In connection with the redemption, the Company wrote off $1.3 million in unamortized debt issuance costs as a charge against interest expense. In addition, the Company incurred a $3.9 million redemption premium and received proceeds of $2.9 million from the termination of its $175.0 million interest rate swap agreements. As a result, the redemption of the 2017 Notes resulted in a net loss of $0.9 million on extinguishment of debt in the second quarter of fiscal 2013.

 

9


Based on quoted market prices, the fair value of the Company’s $250.0 million 7.0% Senior Notes due August 2020 (2020 Notes) was $271.3 million and $272.5 million as of May 2, 2014, and October 25, 2013, respectively. The carrying amounts of the secured credit facility, U.S. Term Loan and Euro Term Loan approximate fair value. Estimates of fair value for the 2020 Notes are based on quoted market prices, and considered Level 2 inputs as defined in the fair value hierarchy, described in Note 12.

Government refundable advances consist of payments received from the Canadian government to assist in research and development related to commercial aviation. The repayment of this advance is based on year-over-year commercial aviation revenue growth at CMC beginning in 2014. Imputed interest on the advance was 4.2% at May 2, 2014. The discounted value of debt recognized was $52.1 million and $56.9 million as of May 2, 2014, and October 25, 2013, respectively.

 

12. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy of fair value measurements is described below:

Level 1 – Valuations are based on quoted prices that the Company has the ability to obtain in actively traded markets for identical assets and liabilities. Since valuations are based on quoted prices that are readily and regularly available in an active market or exchange traded market, a valuation of these instruments does not require a significant degree of judgment.

Level 2 – Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3 – Valuations are based on model-based techniques for which some or all of the assumptions are obtained from indirect market information that is significant to the overall fair value measurement and which require a significant degree of management judgment.

The following table sets forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy at May 2, 2014, and October 25, 2013.

 

(In thousands)    Level 2  
     May 2,
          2014          
     October 25,
          2013          
 

Assets:

     

Derivative contracts designated as hedging instruments

   $ 2,452       $ 2,270   

Derivative contracts not designated as hedging instruments

     3,739         3,670   

Embedded derivatives

     1,934         706   

Liabilities:

     

Derivative contracts designated as hedging instruments

   $ 10,179       $ 4,541   

Derivative contracts not designated as hedging instruments

     17         122   

Embedded derivatives

     719         344   
(In thousands)    Level 3  
     May 2,
2014
     October 25,
2013
 

Liabilities:

     

Contingent purchase obligation

   $ 5,000       $ 4,000   

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency. The fair value is determined by calculating the difference between quoted exchange rates

 

10


at the time the contract was entered into and the period-end exchange rate. These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s derivative contracts consist of foreign currency exchange contracts and interest rate swap agreements. These derivative contracts are over the counter and their fair value is determined using modeling techniques that include market inputs such as interest rates, yield curves, and currency exchange rates. These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s contingent purchase obligations consist of additional contingent consideration in connection with the acquisition of Sunbank of $5.0 million as of May 2, 2014. The contingent considerations will be payable to the sellers if certain performance objectives are met following the acquisition in accordance with the terms of the purchase agreement. The values recorded on the balance sheet were derived from the estimated probability that the performance objectives will be met. The contingent purchase obligations are categorized as Level 3 in the fair value hierarchy. The Company paid $4.0 million of contingent consideration in the second fiscal quarter of 2014 for satisfaction of its obligation related to Eclipse.

 

13. The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and has used interest rate swap contracts for the purpose of minimizing exposure to changes in foreign currency exchange rates on business transactions and interest rates, respectively. The Company’s policy is to execute such instruments with banks the Company believes to be creditworthy and not to enter into derivative financial instruments for speculative purposes. These derivative financial instruments do not subject the Company to undue risk, as gains and losses on these instruments generally offset gains and losses on the underlying assets, liabilities, or anticipated transactions that are being hedged.

All derivative financial instruments are recorded at fair value in the consolidated balance sheet. For a derivative that has not been designated as an accounting hedge, the change in the fair value is recognized immediately through earnings. For a derivative that has been designated as an accounting hedge of an existing asset or liability (a fair value hedge), the change in the fair value of both the derivative and underlying asset or liability is recognized immediately through earnings. For a derivative designated as an accounting hedge of an anticipated transaction (a cash flow hedge), the change in the fair value is recorded on the consolidated balance sheet in accumulated other comprehensive income (AOCI) to the extent the derivative is effective in mitigating the exposure related to the anticipated transaction. The change in the fair value related to the ineffective portion of the hedge, if any, is immediately recognized in earnings. The amount recorded within AOCI is reclassified into earnings in the same period during which the underlying hedged transaction affects earnings.

The fair values of derivative instruments are presented on a gross basis, as the Company does not have any derivative contracts which are subject to master netting arrangements. The Company did not have any hedges with credit-risk-related contingent features or that required the posting of collateral as of May 2, 2014. The cash flows from derivative contracts are recorded in operating activities in the consolidated statement of cash flows.

Foreign Currency Forward Exchange Contracts

The Company transacts business in various foreign currencies which subjects the Company’s cash flows and earnings to exposure related to changes in foreign currency exchange rates. These exposures arise primarily from purchases or sales of products and services from third parties. Foreign currency forward exchange contracts provide for the purchase or sale of foreign currencies at specified future dates at specified exchange rates, and are used to offset changes in the fair value of certain assets or liabilities or forecasted cash flows resulting from transactions denominated in foreign currencies. As of May 2, 2014, and October 25, 2013, the Company had outstanding foreign currency forward exchange contracts principally to sell U.S. dollars with notional amounts of $361.2 million and $369.0 million, respectively. These notional values consist primarily of contracts for the European euro, British pound sterling and Canadian dollar, and are stated in U.S. dollar equivalents at spot exchange rates at the respective dates.

 

11


Interest Rate Swaps

The Company manages its exposure to interest rate risk by maintaining an appropriate mix of fixed and variable rate debt, which over time should moderate the costs of debt financing. When considered necessary, the Company may use financial instruments in the form of interest rate swaps to help meet this objective. In fiscal 2010, the Company entered into interest rate swap agreements for $175.0 million on the 2017 Notes. The swap agreements exchanged the fixed interest rate on the 2017 Notes of 6.625% for a variable interest rate. In the second quarter of fiscal 2013, the swap agreements were terminated and the Company redeemed the 2017 Notes with the proceeds from the U.S. Term Loan. The Company recorded a gain on the swap termination of $2.9 million in the second fiscal quarter of 2013.

Embedded Derivative Instruments

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.

Net Investment Hedge

In July 2011, the Company entered into a Euro Term Loan for €125.0 million under the secured credit facility. The Company designated the Euro Term Loan a hedge of the investment in a certain French business unit. The foreign currency gain or loss that is effective as a hedge is reported as a component of AOCI in shareholders’ equity. To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings. There has been no ineffectiveness since inception of the hedge.

Fair Value of Derivative Instruments

Fair values of derivative instruments in the consolidated balance sheet at May 2, 2014, and October 25, 2013, consisted of:

 

(In thousands)                Fair Value  
    

            Classification             

          May 2,
          2014      
       October 25,
          2013          
 

Foreign Currency Forward Exchange Contracts:

            
   Other current assets         $ 4,681         $ 4,547   
   Other assets           1,510           1,393   
   Accrued liabilities           7,556           3,002   
   Other liabilities           2,640           1,661   

Embedded Derivative Instruments:

            
   Other current assets         $ 23         $ 59   
   Other assets           1,911           647   
   Accrued liabilities           415           344   
   Other liabilities           304           0   

 

12


The effect of derivative instruments on the consolidated statement of operations and comprehensive income for the three and six month periods ended May 2, 2014, and April 26, 2013, consisted of:

 

(In thousands)           Three Months Ended     Six Months Ended  
   

Location of

Gain (Loss)

      May 2,
      2014      
    April 26,
      2013      
    May 2,
      2014      
    April 26,
      2013      
 

Fair Value Hedges:

           

Interest rate swap contracts

  

   
 

Interest Expense

    $ 0      $ 342      $ 0      $ 1,058   
 

Loss on

Extinguishment of Debt

      0        2,918        0        2,918   

Embedded derivatives

         
 

Sales

      (1,881     738        866        1,262   

Cash Flow Hedges:

           

Foreign currency forward exchange contracts:

  

   

Amount of gain (loss) recognized in AOCI (effective portion)

  

   
 

AOCI

    $ 9,034      $ (1,703   $ (2,735   $ (1,436

Amount of gain (loss) reclassified from AOCI into income

  

   
 

Sales

      (2,242     (541     (2,741     (631

Net Investment Hedges:

         

Euro Term Loan

 

AOCI

    $ (556   $ 1,991      $ (28   $ (424

During the first six months of fiscal 2014 and 2013, the Company recorded a gain of $0.8 million and a loss of $1.8 million, respectively, on foreign currency forward exchange contracts that have not been designated as an accounting hedge. These foreign currency exchange losses are included in selling, general and administrative expense.

There was no significant impact to the Company’s earnings related to the ineffective portion of any hedging instruments during the first six months of fiscal 2014 and 2013. In addition, there was no significant impact to the Company’s earnings when a hedged firm commitment no longer qualified as a fair value hedge or when a hedged forecasted transaction no longer qualified as a cash flow hedge during the first six months of fiscal 2014 and 2013.

Amounts included in AOCI are reclassified into earnings when the hedged transaction settles. The Company expects to reclassify approximately $5.4 million of net loss into earnings over the next 12 months. The maximum duration of the Company’s foreign currency cash flow hedge contracts at May 2, 2014, is 24 months.

 

14. On December 5, 2013, the Company announced the acceleration of its plans to consolidate certain facilities and create cost efficiencies through shared services in sales, general and administrative support functions. These integration activities are expected to result in charges and expenses of approximately $40 million. The Company expects to incur costs of $25 million to $30 million in fiscal 2014 to support these efforts, with the balance to be incurred in fiscal 2015. The costs are mainly for severance, relocation of facilities and losses on the write off of certain property, plant and equipment. In the first six months of 2014, restructuring expense totaled $8.9 million, reflecting a $2.5 million loss on the write off of certain property, plant and equipment and $4.1 million in severance. The Company has recorded an accrued liability for $4.0 million for these activities as of May 2, 2014.

 

15.

On March 5, 2014, the Company entered into a Consent Agreement (CA) with the U.S. Department of State’s Directorate of Defense Trade Controls Office of Defense Trade Controls Compliance (DTCC) to resolve alleged International Traffic in Arms Regulations (ITAR) civil violations. The CA settles the pending ITAR compliance matter with the DTCC previously reported by the Company that resulted from voluntary reports the

 

13


  Company filed with DTCC that disclosed possible technical and administrative violations of the ITAR. The CA has a three-year term and provides for: (i) a payment of $20 million, $10 million of which is suspended and eligible for offset credit based on verified expenditures for past and future remedial compliance measures; (ii) the appointment of an external Special Compliance Official to oversee compliance with the CA and the ITAR; (iii) two external audits of the Company’s ITAR compliance program; and (iv) continued implementation of ongoing remedial compliance measures and additional remedial compliance measures related to automated systems and ITAR compliance policies, procedures, and training.

The settlement amount in the CA is consistent with the amount proposed by DTCC in August 2013, for which the Company estimated and recorded a $10 million charge in the fiscal quarter ended July 26, 2013. The $10 million portion of the settlement that is not subject to suspension will be paid in installments, with $4 million paid in March 2014, and $2 million to be paid in each of March 2015, 2016, and 2017. The Company expects some part of recent investments made in our ITAR compliance program will be eligible for credit against the suspended portion of the settlement amount, which include: additional staffing, ongoing implementation of a new software system, employee training, and establishment of a regular compliance audit program and corrective action process. The Company expects recent and future investments in remedial compliance measures will be sufficient to cover the $10 million suspended payment.

 

16. Segment information:

Business segment information includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

 

(In thousands)    Three Months Ended     Six Months Ended  
     May 2,
2014
    April 26,
2013
    May 2,
2014
    April 26,
2013
 

Sales

        

Avionics & Controls

   $ 195,601      $ 192,130      $ 396,040      $ 366,700   

Sensors & Systems

     210,734        176,964        397,823        348,774   

Advanced Materials

     123,239        130,468        240,691        242,050   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Sales

   $       529,574      $ 499,562      $     1,034,554      $         957,524   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings From Continuing Operations Before Income Taxes

  

Avionics & Controls

   $ 21,567      $ 21,465      $ 46,331      $ 40,054   

Sensors & Systems

     23,099        23,207        43,337        42,208   

Advanced Materials

     27,367        28,623        43,371        46,267   
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment Earnings

     72,033        73,295        133,039        128,529   

Corporate expense

     (17,037     (15,855     (32,256     (32,431

Interest income

     137        148        257        249   

Interest expense

     (8,439     (11,482     (17,069     (21,926

Loss on extinguishment of debt

     0        (946     0        (946
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 46,694      $         45,160      $ 83,971      $ 73,475   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

17. The following schedules set forth condensed consolidating financial information as required by Rule 3-10 of Securities and Exchange Commission Regulation S-X as of May 2, 2014, and October 25, 2013, and for the applicable periods ended May 2, 2014, and April 26, 2013, for (a) Esterline Technologies Corporation (the Parent); (b) on a combined basis, the current subsidiary guarantors (Guarantor Subsidiaries) of the secured credit facility and the 2020 Notes; and (c) on a combined basis, the subsidiaries that are not guarantors of the secured credit facility and the 2020 Notes (Non-Guarantor Subsidiaries). The Guarantor Subsidiaries are direct and indirect wholly-owned subsidiaries of Esterline Technologies Corporation and have fully and unconditionally, jointly and severally, guaranteed the secured credit facility and the 2020 Notes.

 

14


Condensed Consolidating Balance Sheet as of May 2, 2014.

 

(In thousands)                              
                  Parent     Guarantor
      Subsidiaries
    Non-
Guarantor
      Subsidiaries
        Eliminations                     Total  

Assets

         

Current Assets

         

Cash and cash equivalents

    $             9,577        $               5,535        $           192,331        $                    0        $         207,443   

Cash in escrow

    0        0        0        0        0   

Accounts receivable, net

    573        147,258        207,106        0        354,937   

Inventories

    0        207,140        282,090        0        489,230   

Income tax refundable

    4,413        (72     3,140        0        7,481   

Deferred income tax benefits

    25,660        134        21,306        0        47,100   

Prepaid expenses

    84        9,689        17,144        0        26,917   

Other current assets

    86        114        5,516        0        5,716   

 

 

Total Current Assets

    40,393        369,798        728,633        0        1,138,824   

Property, Plant &
Equipment, Net

    1,562        171,627        193,054        0        366,243   

Goodwill

    0        361,492        781,734        0        1,143,226   

Intangibles, Net

    0        159,449        421,944        0        581,393   

Debt Issuance Costs, Net

    4,575        0        784        0        5,359   

Deferred Income
Tax Benefits

    17,323        (2     54,009        0        71,330   

Other Assets

    261        9,405        9,373        0        19,039   

Amounts Due From (To)
Subsidiaries

    0        603,074        0        (603,074     0   

Investment in Subsidiaries

    2,740,359        1,004,610        350,270        (4,095,239     0   

 

 

Total Assets

    $      2,804,473        $        2,679,453        $        2,539,801        $     (4,698,313     $      3,325,414   

 

 

 

15


(In thousands)                              
                  Parent     Guarantor
      Subsidiaries
    Non-
Guarantor
      Subsidiaries
        Eliminations                     Total  

Liabilities and Shareholders’ Equity

  

       

Current Liabilities

         

Accounts payable

    $             1,149        $             34,424        $            83,253        $                    0        $         118,826   

Accrued liabilities

    14,753        88,111        139,751        0        242,615   

Current maturities of
long-term debt

    8,750        376        8,854        0        17,980   

Deferred income tax
liabilities

    469        0        2,258        0        2,727   

Federal and foreign
income taxes

    18        (11,207     17,201        0        6,012   

 

 

Total Current Liabilities

    25,139        111,704        251,317        0        388,160   

Credit Facilities

    130,000        0        0        0        130,000   

Long-Term Debt, Net

    407,500        55,283        56,471        0        519,254   

Deferred Income Tax
Liabilities

    55,282        (6     129,566        0        184,842   

Pension and Post-
Retirement Obligations

    17,418        682        45,650        0        63,750   

Other Liabilities

    16,907        3,944        28,580        0        49,431   

Amounts Due To (From)
Subsidiaries

    162,250        0        415,547        (577,797     0   

Shareholders’ Equity

    1,989,977        2,507,846        1,612,670        (4,120,516     1,989,977   

 

 

Total Liabilities and
Shareholders’ Equity

    $      2,804,473        $        2,679,453        $       2,539,801        $     (4,698,313     $      3,325,414   

 

 

 

16


Condensed Consolidating Statement of Operations and Comprehensive Income (Loss) for the three month period ended May 2, 2014.

 

(In thousands)                               
                   Parent     Guarantor
      Subsidiaries
   

Non-

Guarantor
      Subsidiaries

        Eliminations                     Total  

Net Sales

     $                    0        $           256,254        $           274,396        $            (1,076     $         529,574   

Cost of Sales

     0        164,735        183,570        (1,076     347,229   

 

 
     0        91,519        90,826        0        182,345   

Expenses

          

Selling, general and
administrative

     0        42,044        56,426        0        98,470   

Research, development
and engineering

     0        13,297        13,504        0        26,801   

Restructuring charges

     0        1,248        830        0        2,078   

 

 

Total Expenses

     0        56,589        70,760        0        127,349   

 

 

Operating Earnings From
Continuing Operations

     0        34,930        20,066        0        54,996   

Interest Income

     (3,755     (1,913     (13,697     19,228        (137

Interest Expense

     6,237        6,730        14,700        (19,228     8,439   

Loss on Extinguishment of Debt

     0        0        0        0        0   

 

 

Earnings (Loss) From
Continuing Operations
Before Income Taxes

     (2,482     30,113        19,063        0        46,694   

Income Tax Expense
(Benefit)

     (520     6,381        3,289        0        9,150   

 

 

Earnings (Loss) From
Continuing Operations
Including Noncontrolling
Interests

     (1,962     23,732        15,774        0        37,544   

Earnings Attributable to
Noncontrolling Interests

     0        0        (297     0        (297

 

 

Earnings (Loss) From
Continuing Operations
Attributable to Esterline

     (1,962     23,732        15,477        0        37,247   

Earnings (Loss) From
Discontinued Operations
Attributable to Esterline,
Net of Tax

     (343     0        0        0        (343

Equity in Net Earnings of
Consolidated Subsidiaries

     39,209        802        1,926        (41,937     0   

 

 

Net Earnings (Loss)
Attributable to Esterline

     $           36,904        $             24,534        $             17,403        $          (41,937     $           36,904   

 

 

Comprehensive Income
(Loss)

     $           75,488        $             25,065        $             56,268        $          (76,700     $           80,121   

 

17


Condensed Consolidating Statement of Operations and Comprehensive Income (Loss) for the six month period ended May 2, 2014.

 

(In thousands)                               
             Parent       
 
Guarantor
  Subsidiaries
  
  
   
 
 
Non-
Guarantor
  Subsidiaries
  
  
  
      Eliminations        Total   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Sales

   $                     0      $         485,383      $         551,689      $           (2,518   $     1,034,554   

Cost of Sales

     0        312,415        369,017        (2,518     678,914   

 

 
     0        172,968        182,672        0        355,640   

Expenses

          

Selling, general and
administrative

     0        82,468        112,208        0        194,676   

Research, development
and engineering

     0        25,553        27,754        0        53,307   

Restructuring charges

     0        4,321        2,553        0        6,874   

 

 

Total Expenses

     0        112,342        142,515        0        254,857   

 

 

Operating Earnings From
Continuing Operations

     0        60,626        40,157        0        100,783   

Interest Income

     (7,751     (3,938     (28,374     39,806        (257

Interest Expense

     12,573        13,787        30,515        (39,806     17,069   

Loss on Extinguishment of Debt

     0        0        0        0        0   

 

 

Earnings (Loss) From
Continuing Operations
Before Income Taxes

     (4,822     50,777        38,016        0        83,971   

Income Tax Expense
(Benefit)

     (996     10,676        6,583        0        16,263   

 

 

Earnings (Loss) From
Continuing Operations
Including Noncontrolling
Interests

     (3,826     40,101        31,433        0        67,708   

Earnings Attributable to
Noncontrolling Interests

     0        0        (383     0        (383

 

 

Earnings (Loss) From
Continuing Operations
Attributable to Esterline

     (3,826     40,101        31,050        0        67,325   

Earnings (Loss) From
Discontinued Operations
Attributable to Esterline,
Net of Tax

     (343     0        0        0        (343

Equity in Net Earnings of
Consolidated Subsidiaries

     71,151        1,234        1,320        (73,705     0   

 

 

Net Earnings (Loss)
Attributable to Esterline

   $ 66,982      $ 41,335      $ 32,370      $ (73,705   $ 66,982   

 

 

Comprehensive Income
(Loss)

   $ 72,667      $ 42,469      $ 44,634      $ (90,087   $ 69,683   

 

18


Condensed Consolidating Statement of Cash Flows for the six month period ended May 2, 2014.

 

(In thousands)                               
                 Parent     Guarantor
      Subsidiaries
   

Non-

Guarantor
      Subsidiaries

        Eliminations                     Total  

Cash Flows Provided (Used) by Operating Activities

  

   

Net earnings (loss) including
noncontrolling interests

     $         67,365        $             41,335        $             32,370        $          (73,705     $            67,365   

Depreciation & amortization

     0        22,722        36,560        0        59,282   

Deferred income taxes

     (2,708     16        (5,718     0        (8,410

Share-based compensation

     0        2,891        3,757        0        6,648   

Gain on sale of capital assets

     0        0        0        0        0   

Working capital changes, net
of effect of acquisitions:

          

Accounts receivable

     (257     11,715        21,873        0        33,331   

Inventories

     0        (7,944     (25,541     0        (33,485

Prepaid expenses

     33        (3,634     (4,471     0        (8,072

Other current assets

     0        1        (277     0        (276

Accounts payable

     (565     (132     (9,953     0        (10,650

Accrued liabilities

     (6,625     (1,292     (5,307     0        (13,224

Federal & foreign
income taxes

     (6,803     22,219        (19,170     0        (3,754

Other liabilities

     5,308        64        (6,959     0        (1,587

Other, net

     (242     (3,170     696        0        (2,716

 

 
     55,506        84,791        17,860        (73,705     84,452   

Cash Flows Provided (Used) by Investing Activities

  

   

Purchases of capital assets

     (149     (7,833     (13,315     0        (21,297

Proceeds from sale
of capital assets

     0        0        0        0        0   

Acquisitions of business,
net of cash acquired

     0        (44,043     0        0        (44,043

 

 
     (149     (51,876     (13,315     0        (65,340

 

19


(In thousands)                                
             Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations      Total  

Cash Flows Provided (Used) by Financing Activities

  

Proceeds provided by stock
issuance under employee
stock plans

     22,957        0        0        0         22,957   

Excess tax benefits from
stock options exercises

     5,297        0        0        0         5,297   

Repayment of long-term
credit facilities

     (25,000     0        0        0         (25,000

Repayment of long-term debt

     (4,375     (205     (14,722     0         (19,302

Proceeds from issuance of
long-term credit facilities

     25,000        0        0        0         25,000   

Dividends paid to
noncontrolling interests

     0        0        (780     0         (780

Debt and other issuance costs

     0        0        0        0         0   

Net change in intercompany
financing

     (77,490     (32,008     35,793        73,705         0   

 

 
     (53,611     (32,213     20,291        73,705         8,172   

Effect of foreign exchange
rates on cash and
cash equivalents

     5        (43     1,019        0         981   

 

 

Net increase (decrease) in
cash and cash equivalents

     1,751        659        25,855        0         28,265   

Cash and cash equivalents
– beginning of year

     7,826        4,876        166,476        0         179,178   

 

 

Cash and cash equivalents
– end of year

   $                 9,577      $     5,535      $ 192,331      $ 0       $           207,443   

 

 

 

20


Condensed Consolidating Balance Sheet as of October 25, 2013.

 

(In thousands)                                  
     Parent      Guarantor
    Subsidiaries
     Non-
Guarantor
    Subsidiaries
         Eliminations     Total  

Assets

             

Current Assets

             

Cash and cash equivalents

   $ 7,826       $ 4,876       $ 166,476       $ 0      $ 179,178   

Cash in escrow

     4,018         0         0         0        4,018   

Accounts receivable, net

     316         154,492         228,858         0        383,666   

Inventories

     0         190,830         256,833         0        447,663   

Income tax refundable

     0         6,526         0         0        6,526   

Deferred income tax benefits

     26,731         171         20,375         0        47,277   

Prepaid expenses

     117         5,510         12,556         0        18,183   

Other current assets

     86         115         5,003         0        5,204   

 

 

Total Current Assets

     39,094         362,520         690,101         0        1,091,715   

Property, Plant &
Equipment, Net

     1,754         175,402         194,041         0        371,197   

Goodwill

     0         344,995         783,982         0        1,128,977   

Intangibles, Net

     0         144,222         436,727         0        580,949   

Debt Issuance Costs, Net

     5,252         0         959         0        6,211   

Deferred Income Tax
Benefits

     16,782         0         55,058         0        71,840   

Other Assets

     18         3,692         7,513         0        11,223   

Amounts Due From (To)
Subsidiaries

     0         549,307         0         (549,307     0   

Investment in Subsidiaries

     2,588,478         979,123         349,104         (3,916,705     0   

 

 

Total Assets

   $       2,651,378       $       2,559,261       $       2,517,485       $ (4,466,012   $       3,262,112   

 

 

 

21


(In thousands)                              
    Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations     Total  

Liabilities and Shareholders’ Equity

         

Current Liabilities

         

Accounts payable

  $ 1,714      $ 29,064      $ 92,819      $ 0      $ 123,597   

Accrued liabilities

    21,652        87,826        144,083        0        253,561   

Current maturities of
long-term debt

    8,750        237        12,292        0        21,279   

Deferred income tax
liabilities

    568        24        1,715        0        2,307   

Federal and foreign
income taxes

    2,408        (27,399     32,339        0        7,348   

 

 

Total Current Liabilities

    35,092        89,752        283,248        0        408,092   

Credit Facilities

    130,000        0        0        0        130,000   

Long-Term Debt, Net

    411,875        55,562        70,422        0        537,859   

Deferred Income Tax
Liabilities

    57,757        (7     135,369        0        193,119   

Pension and Post-Retirement
Obligations

    17,500        618        49,984        0        68,102   

Other Liabilities

    12,298        194        27,696        0        40,188   

Amounts Due To (From)
Subsidiaries

    102,104        0        405,018        (507,122     0   

Shareholders’ Equity

    1,884,752        2,413,142        1,545,748        (3,958,890     1,884,752   

 

 

Total Liabilities and
Shareholders’ Equity

  $       2,651,378      $       2,559,261      $       2,517,485      $     (4,466,012)      $       3,262,112   

 

 

 

22


Condensed Consolidating Statement of Operations and Comprehensive Income (Loss) for the three month period ended April 26, 2013.

(In thousands)

            Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations                     Total  

Net Sales

  $ 0      $ 230,311      $ 270,151      $ (900   $ 499,562   

Cost of Sales

    0        141,178        177,908        (900     318,186   

 

 
    0        89,133        92,243        0        181,376   

Expenses

         

Selling, general and
administrative

    0        39,105        59,173        0        98,278   

Research, development
and engineering

    0        13,706        11,952        0        25,658   

Restructuring charges

    0        0        0        0        0   

 

 

Total Expenses

    0        52,811        71,125        0        123,936   

 

 

Operating Earnings From
Continuing Operations

    0        36,322        21,118        0        57,440   

Interest Income

    (3,992     (1,978     (13,136     18,958        (148

Interest Expense

    9,152        6,646        14,642        (18,958     11,482   

Loss on Extinguishment
of Debt

    946        0        0        0        946   

 

 

Earnings (Loss) From
Continuing Operations
Before Income Taxes

    (6,106     31,654        19,612        0        45,160   

Income Tax Expense
(Benefit)

    (1,273     6,468        4,287        0        9,482   

 

 

Earnings (Loss) From
Continuing Operations
Including Noncontrolling
Interests

    (4,833     25,186        15,325        0        35,678   

Earnings Attributable to
Noncontrolling Interests

    0        0        (156     0        (156

 

 

Earnings (Loss) From
Continuing Operations
Attributable to Esterline

    (4,833     25,186        15,169        0        35,522   

Earnings (Loss) From
Discontinued Operations
Attributable to Esterline,
Net of Tax

    0        0        0        0        0   

Equity in Net Earnings of
Consolidated Subsidiaries

    40,355        (275     30        (40,110     0   

 

 

Net Earnings (Loss)
Attributable to Esterline

  $ 35,522      $ 24,911      $ 15,199      $ (40,110   $ 35,522   

 

 

Comprehensive Income
(Loss)

  $ 2,500      $ 24,229      $ (17,184   $ (8,178   $ 1,367   

 

23


Condensed Consolidating Statement of Operations and Comprehensive Income (Loss) for the six month period ended April 26, 2013.

(In thousands)

            Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations                     Total  

Net Sales

  $ 0      $ 437,010      $ 522,321      $ (1,807   $ 957,524   

Cost of Sales

    0        273,044        344,566        (1,807     615,803   

 

 
    0        163,966        177,755        0        341,721   

Expenses

         

Selling, general and
administrative

    0        74,836        122,053        0        196,889   

Research, development
and engineering

    0        24,764        23,970        0        48,734   

Restructuring charges

    0        0        0        0        0   

 

 

Total Expenses

    0        99,600        146,023        0        245,623   

 

 

Operating Earnings From
Continuing Operations

    0        64,366        31,732        0        96,098   

Interest Income

    (7,652     (3,695     (27,824     38,922        (249

Interest Expense

    17,233        12,967        30,648        (38,922     21,926   

Loss on Extinguishment
of Debt

    946        0        0        0        946   

 

 

Earnings (Loss) From
Continuing Operations
Before Income Taxes

    (10,527     55,094        28,908        0        73,475   

Income Tax Expense
(Benefit)

    (2,223     8,914        5,185        0        11,876   

 

 

Earnings (Loss) From
Continuing Operations
Including Noncontrolling
Interests

    (8,304     46,180        23,723        0        61,599   

Earnings Attributable to
Noncontrolling Interests

    0        0        (966     0        (966

 

 

Earnings (Loss) From
Continuing Operations
Attributable to Esterline

    (8,304     46,180        22,757        0        60,633   

Earnings (Loss) From
Discontinued Operations
Attributable to Esterline,
Net of Tax

    0        0        0        0        0   

Equity in Net Earnings of
Consolidated Subsidiaries

    68,937        383        30        (69,350     0   

 

 

Net Earnings (Loss)
Attributable to Esterline

  $ 60,633      $ 46,563      $ 22,787      $ (69,350   $ 60,633   

 

 

Comprehensive Income
(Loss)

  $ 41,276      $ 45,492      $ 8,409      $ (56,919   $ 38,258   

 

24


Condensed Consolidating Statement of Cash Flows for the six month period ended April 26, 2013.

 

(In thousands)                              
            Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations                 Total  

Cash Flows Provided (Used) by Operating Activities

  

     

Net earnings (loss) including
noncontrolling interests

  $ 61,599      $ 46,563      $ 22,787      $ (69,350   $ 61,599   

Depreciation & amortization

    0        20,776        35,512        0        56,288   

Deferred income taxes

    13,077        (325     (18,428     0        (5,676

Share-based compensation

    0        2,360        3,298        0        5,658   

Gain on sale of capital assets

    0        (308     (387     0        (695

Working capital changes, net
of effect of acquisitions:

         

Accounts receivable

    (682     10,653        31,620        0        41,591   

Inventories

    0        (8,887     (9,392     0        (18,279

Prepaid expenses

    (63     (1,519     (392     0        (1,974

Other current assets

    42        415        (738     0        (281

Accounts payable

    122        (506     806        0        422   

Accrued liabilities

    (3,117     (2,171     (8,299     0        (13,587

Federal & foreign
income taxes

    2,831        (2,467     (3,172     0        (2,808

Other liabilities

    7,824        (7,058     (3,978     0        (3,212

Other, net

    1,284        5,789        (3,435     0        3,638   

 

 
    82,917        63,315        45,802        (69,350     122,684   

Cash Flows Provided (Used) by Investing Activities

  

     

Purchases of capital assets

    (35     (8,495     (16,555     0        (25,085

Proceeds from sale
of capital assets

    0        308        387        0        695   

Acquisitions of business,
net of cash acquired

    0        0        (40,689     0        (40,689

 

 
    (35     (8,187     (56,857     0        (65,079

 

25


(In thousands)                              
            Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations                 Total  

Cash Flows Provided (Used) by Financing Activities

  

     

Proceeds provided by stock
issuance under employee
stock plans

    15,201        0        0        0        15,201   

Excess tax benefits from
stock options exercises

    1,820        0        0        0        1,820   

Repayment of long-term
credit facilities

    (40,000     0        0        0        (40,000

Repayment of long-term debt

    (175,000     (165     (22,293     0        (197,458

Proceeds from issuance of
long-term credit facilities

    175,000        0        0        0        175,000   

Dividends paid to
noncontrolling interests

    0        0        (962     0        (962

Debt and other issuance costs

    (453     0        0        0        (453

Net change in intercompany
financing

    (65,217     (54,969     50,836        69,350        0   

 

 
    (88,649     (55,134     27,581        69,350        (46,852

Effect of foreign exchange
rates on cash and
cash equivalents

    (5     (9     (2,237     0        (2,251

 

 

Net increase (decrease) in
cash and cash equivalents

    (5,772     (15     14,289        0        8,502   

Cash and cash equivalents
– beginning of year

    16,770        1,324        142,581        0        160,675   

 

 

Cash and cash equivalents
– end of year

  $ 10,998      $ 1,309      $ 156,870      $ 0      $ 169,177   

 

 

 

26


Item 2.            Management’s Discussion and Analysis of Financial Condition and

                        Results of Operations

Overview

We operate our businesses in three segments: Avionics & Controls, Sensors & Systems and Advanced Materials. Our segments are structured around our technical capabilities. Sales in all segments include domestic, international, defense and commercial customers.

The Avionics & Controls segment includes avionics systems, control and communication systems, and interface technologies capabilities. Avionics systems designs and develops cockpit systems integration and avionics solutions for commercial and military applications. Control and communication systems designs and manufactures technology interface systems for military and commercial aircraft and land- and sea-based military vehicles. Additionally, control and communication systems designs and manufactures military audio and data products for severe battlefield environments, embedded communication intercept receivers for signal intelligence applications, as well as communication control systems to enhance security and aural clarity in military applications. Interface technologies manufactures and develops custom control panels, input systems for medical, industrial, military and gaming industries.

The Sensors & Systems segment includes power systems, connection technologies, and advanced sensors capabilities. Power systems develops and manufactures electrical power switching and other related systems, principally for aerospace and defense customers. Connection technologies develops and manufactures highly engineered connectors for harsh environments and serves the aerospace, defense & space, power generation, rail and industrial equipment markets. Advanced sensors develops and manufactures high-precision temperature and pressure sensors for aerospace and defense customers.

The Advanced Materials segment includes engineered materials and defense technologies capabilities. Engineered materials develops and manufactures thermally engineered components and high-performance elastomer products used in a wide range of commercial aerospace and military applications. Defense technologies develops and manufactures combustible ordnance components and airborne countermeasure devices for military customers.

Our current business and strategic plan focuses on the continued development of our products principally for aerospace and defense markets. We are concentrating our efforts to expand our capabilities in these markets and anticipate the global needs of our customers and respond to such needs with comprehensive solutions. These efforts focus on continuous research and new product development, acquisitions and strategic realignments of operations to expand our capabilities as a more comprehensive supplier to our customers across our entire product offering.

On December 5, 2013, we announced the acceleration of our plans to consolidate certain facilities and create cost efficiencies through shared services in sales, general and administrative and support functions. Our integration activities are expected to result in charges and expenses of approximately $40 million over the next two years. We expect to incur costs of $25 million to $30 million in fiscal 2014, with the balance to be incurred in fiscal 2015. The costs include severance, relocation of facilities and losses from the write off of certain property, plant and equipment. Expense savings on short-cycle activities will commence in fiscal 2014, with substantially more savings projected in fiscal 2015. We expect these projects to result in savings in excess of $15 million annually commencing in fiscal 2016. The projects have payback periods of approximately two years.

Total restructuring expenses were $3.5 million, or 0.7% of sales, in the second fiscal quarter of 2014, of which $2.1 million is reported separately as restructuring expenses and $1.4 million is included in costs of goods sold. Restructuring expenses were mainly comprised of $1.8 million in severance. Total restructuring expenses were $8.9 million, or 0.9% of sales, in the first six months of fiscal 2014, of which $6.9 million is reported separately as restructuring expenses and $2.1 million is included in costs of goods sold. Restructuring expenses were mainly comprised of $4.1 million in severance and a $2.5 million loss on the write off of certain property, plant and equipment.

On December 20, 2013, we acquired the Sunbank Family of Companies, LLC (Sunbank) for $51 million. The purchase price included $5 million in additional contingent consideration based upon achievement of certain sales

 

27


levels over a two-year period. Sunbank is a manufacturer of electrical cable accessories, connectors, and flexible conduit systems. Sunbank is included in the Sensors & Systems segment.

On February 4, 2013, we acquired the Gamesman Group (Gamesman) for $40.8 million. Gamesman is a global supplier of input devices principally serving the gaming industry. Gamesman is included in the Avionics & Controls segment.

For the second fiscal quarter of 2014, earnings from continuing operations were $37.2 million, or $1.15 per diluted share, compared to $35.5 million, or $1.12 per diluted share, in the second fiscal quarter of 2013. For the first six months of fiscal 2014, earnings from continuing operations were $67.3 million, or $2.08 per diluted share, compared to $60.6 million, or $1.92 per diluted share, during the prior-year period.

Total sales in the second fiscal quarter of 2014 increased 6.0% over the prior-year period, reflecting higher sales mainly in the Sensors & Systems segment, partially offset by lower sales in Advanced Materials. A 19% increase in Sensors & Systems sales mainly reflected higher sales of connection technologies due to increased demand for industrial and commercial aviation applications and incremental sales from the acquisition of Sunbank. The decrease in Advanced Materials sales reflected lower sales of defense technologies. A 1.8% increase in the Avionics & Controls segment principally reflected strong sales from Gamesman. Total sales were impacted by reductions in defense spending mainly due to the continued uncertainty related to defense spending. The impact of this uncertainty is yet to be fully determined, and lack of clarity will likely result in downward pressure for some period of time.

Operating earnings from continuing operations of $55.0 million decreased 4.3% over the prior-year period, mainly due to lower gross margin. Consolidated gross margin decreased to 34.4% in the second fiscal quarter of 2014 compared to 36.3% in the prior-year period. The decrease mainly reflected the reduction in Sensors & Systems gross margin to 32.6% from 38.2% in the prior-year period due to decreased aftermarket sales and lower gross margins of Sunbank.

Research, development and engineering and selling, general and administrative increased modestly over the prior-year period.

Interest expense decreased $3.0 million over the prior-year period due to lower borrowings.

For the second fiscal quarter of 2014, the income tax rate declined to 19.6% from 21.0% in the prior-year period and net earnings were $36.9 million, or $1.14 per diluted share, compared to $35.5 million, or $1.12 per diluted share, in the prior-year period.

For the first six month period of fiscal 2014, total sales increased 8.0% over the prior-year period to $1.0 billion, reflecting higher sales at Avionics & Controls and Sensors & Systems. Consolidated sales reflected a 27-week period in the first six months of fiscal 2014 compared to a 26-week period in the prior-year period. Avionics & Controls segment sales benefited from the incremental sales from the Gamesman acquisition. Sensors & Systems segment sales benefited from favorable foreign exchange rate changes, higher sales volumes of connection technologies and incremental sales from the Sunbank acquisition. Advanced Materials sales decreased on lower sales of combustible ordnance and flare countermeasure devices, substantially offset by higher sales of engineered materials for defense and commercial aviation applications.

Consolidated gross margin decreased to 34.4% in the first six months of fiscal 2014 compared with 35.7% in the prior-year period. This was due to lower gross margins from sales of Sensors & Systems. Research, development and engineering spending increased $4.6 million over the prior-year period to 5.2% of sales. Selling, general and administrative expense, as a percent of sales, decreased 1.7 percentage points over the prior-year period to 18.8% of sales. The decrease in selling, general and administrative expense as a percent of sales mainly reflected higher sales volumes. Earnings from continuing operations were impacted by an increase in the income tax rate to 19.4% from 16.2% in the prior-year period, reflecting certain discrete tax benefits recorded in the prior-year period.

In April 2013, we redeemed the $175.0 million 6.625% Senior Notes due March 2017 (2017 Notes). In connection with the redemption, we wrote off $1.3 million in unamortized debt issuance costs as a charge against interest expense. In addition, we incurred a $3.9 million redemption premium and terminated our $175.0 million interest

 

28


rate swap agreements and received proceeds of $2.9 million. As a result, the redemption of the 2017 Notes resulted in a loss of $0.9 million on extinguishment of debt.

Net earnings were $67.0 million, or $2.07 per diluted share, for the first six months of fiscal 2014 compared to $60.6 million, or $1.92 per diluted share, in the prior-year period.

Results of Operations

Three Month Period Ended May 2, 2014, Compared with Three Month Period Ended April 26, 2013

Sales for the second fiscal quarter increased 6.0% over the prior-year period. Sales by segment were as follows:

 

(In thousands)     

Incr./(Decr.)

from prior

    year period    

     Three Months Ended  
          May 2,
2014
       April 26,
2013
 

     Avionics & Controls

       1.8%      $ 195,601         $ 192,130   

     Sensors & Systems

     19.1%        210,734           176,964   

     Advanced Materials

       (5.5)%        123,239           130,468   
         

 

 

      

 

 

 

     Total Net Sales

          $             529,574         $             499,562   
         

 

 

      

 

 

 

The 1.8% increase in sales of Avionics & Controls mainly reflected higher sales at Gamesman of $5 million.

The 19.1% increase in Sensors & Systems principally reflected increased sales of connection technologies and $10 million from incremental sales from the Sunbank acquisition in December 2013. Advanced sensors sales increased $1 million on improved OEM sales partially offset by lower aftermarket sales. Power systems sales increased $9 million mainly due to higher commercial aviation demand. Segment sales also benefited from a stronger euro and U.K. pound relative to the U.S. dollar compared with the prior-year period.

The 5.5% decrease in sales of Advanced Materials principally reflected decreased sales volumes of defense technologies, partially offset by increased sales volumes of engineered materials of $6 million. The decrease in defense technologies sales volumes was due to lower demand for combustible ordnance and flare countermeasure devices. The increase in engineered materials mainly reflected higher sales for defense and commercial aviation applications.

Overall, gross margin was 34.4% and 36.3% for the second fiscal quarter of 2014 and 2013, respectively. Gross profit was $182.3 million and $181.4 million for the second fiscal quarter of 2014 and 2013, respectively. Gross margin was impacted by $1.4 million in restructuring expense in the second fiscal quarter of 2014 and by $0.9 million due to valuing Sunbank’s inventory at fair value.

Avionics & Controls segment gross margin was 36.1% and 36.9% for the second fiscal quarter of 2014 and 2013, respectively. Segment gross profit was $70.7 million compared to $70.8 million in the prior-year period. The slight decrease in segment gross profit principally reflected lower gross profit on sales of cockpit control devices of $6 million, substantially offset by a $5 million increase in gross profit on sales of avionics systems. The decrease in gross profit on cockpit control devices was mainly due to lower sales volumes for defense applications. The increase in gross profit on avionics systems principally reflected higher sales of aviation products for defense applications and a sale of licensed technology.

Sensors & Systems segment gross margin was 32.6% and 38.2% for the second fiscal quarter of 2014 and 2013, respectively. Segment gross profit was $68.7 million compared to $67.6 million in the prior-year period. The increase in gross profit was mainly due to higher sales volumes of connection technologies. The decrease in gross margin reflected lower aftermarket sales of advanced sensors and power systems and higher operating expenses at our advanced sensor operations. In addition, gross margin on segment sales were impacted by valuing Sunbank’s inventory at fair value and its lower gross margins than the overall segment margins.

 

29


Advanced Materials segment gross margin was 34.9% compared to 32.9% for the prior-year period. Segment gross profit was $43.0 million in both the second fiscal quarter of 2014 and in the prior-year period. Gross profit in the second fiscal quarter of 2014 compared to the prior-year period reflected higher sales volumes of engineered materials for defense applications, offset by lower gross profit on decreased sales volumes of combustible ordnance and flare countermeasure devices. Gross margin improved in the second fiscal quarter of 2014 due to higher sales of engineered materials for defense applications.

Selling, general and administrative expenses (which include corporate expenses) totaled $98.5 million, or 18.6% of sales, and $98.3 million, or 19.7% of sales, for the second fiscal quarter of 2014 and 2013, respectively.

Research, development and engineering spending was $26.8 million, or 5.1% of sales, for the second fiscal quarter of 2014 compared with $25.7 million, or 5.1% of sales, for the second fiscal quarter of 2013, mainly reflecting higher research, development and engineering for advanced sensors and connection technologies. Fiscal 2014 research, development and engineering spending is expected to be in the range of approximately 5% to 5.25% of sales.

Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the second fiscal quarter of 2014 totaled $72.0 million, or 13.6% of sales, compared with $73.3 million, or 14.7% of sales, for the second fiscal quarter of 2013. Excluding restructuring expenses of $3.3 million, segment earnings were $75.4 million, or 14.2% of sales, for the second fiscal quarter of 2014.

Avionics & Controls segment earnings were $21.6 million, or 11.0% of sales, in the second fiscal quarter of 2014 and $21.5 million, or 11.2% of sales, in the second fiscal quarter of 2013, mainly reflecting a $4 million increase in avionics systems and interface technologies, substantially offset by a decrease in control and communication systems. Avionics systems earnings benefited from increased gross profit, partially offset by $1.0 million in restructuring expense, mainly severance. Interface technologies earnings benefited from incremental earnings of $2 million from Gamesman, which were substantially offset by lower earnings from sales of interface technologies for medical applications. Control and communication systems earnings were mainly impacted by decreased earnings on lower sales of cockpit control devices.

During the second fiscal quarter of 2014, management performed an impairment test of Eclipse Electronic Systems, Inc.’s (Eclipse) long-lived assets including property, plant and equipment and intangible assets due to the uncertain outlook for sales and earnings over the next five years. The net book value of Eclipse’s long-lived assets at May 2, 2014, totaled $41.5 million. Although sales are currently being delayed and orders pushed out, the forecast of undiscounted cash flow over the remaining useful life of the intangible assets exceeded the book value of Eclipse, and accordingly, no impairment was recorded. If Eclipse’s performance declines further or if there are other changes that impact Eclipse’s outlook, we may incur an impairment loss in a future period that could be material.

Sensors & Systems segment earnings were $23.1 million, or 11.0% of sales, for the second fiscal quarter of 2014 compared with $23.2 million, or 13.1% of sales, for the second fiscal quarter of 2013. Sensors & Systems earnings were impacted by lower gross margin and $1.7 million in restructuring expense.

Advanced Materials segment earnings were $27.4 million, or 22.2% of sales, for the second fiscal quarter of 2014 compared with $28.6 million, or 21.9% of sales, for the second fiscal quarter of 2013, primarily reflecting declines of $0.5 million from lower earnings from sales of combustible ordnance and flare countermeasures and restructuring expense, mainly severance. This decrease in segment earnings was substantially offset by increased gross profit on higher sales of elastomer materials for defense applications.

Interest expense for the second fiscal quarter of 2014 and 2013 was $8.4 million and $11.5 million, respectively, reflecting lower borrowings.

In April 2013, we redeemed the 2017 Notes. In connection with the redemption, we wrote off $1.3 million in unamortized debt issuance costs as a charge against interest expense. In addition, we incurred a $3.9 million redemption premium and received proceeds of $2.9 million from terminating our $175.0 million interest rate swap agreements. As a result, the redemption of the 2017 Notes resulted in a loss of $0.9 million on extinguishment of debt.

 

30


The income tax rate was 19.6% and 21.0% for the second fiscal quarter of 2014 and 2013, respectively. In the second fiscal quarter of 2014, we recognized $0.6 million of discrete tax benefits principally related to the reduction of net deferred income tax liabilities as a result of the enactment of tax laws reducing the U.K. statutory income tax rate. The income tax rate differed from the statutory rate in the second fiscal quarter of 2014 and 2013, as both years benefited from various tax credits and certain foreign interest expense deductions.

To the extent that sales are transacted in a currency other than the functional currency of the operating unit, we are subject to foreign currency fluctuation risk.

We use forward contracts to hedge our foreign currency exchange risk. To the extent that these contracts qualify as hedges under U.S. GAAP, the amount of gain or loss is deferred in Accumulated Other Comprehensive Income (AOCI) until the related sale occurs. Also, we are subject to foreign currency gains or losses from embedded derivatives on backlog denominated in a currency other than the functional currency of our operating companies or its customers. Gains and losses on forward contracts, embedded derivatives, and revaluation of assets and liabilities denominated in a currency other than the functional currency of the Company for the three month periods ended May 2, 2014, and April 26, 2013, are as follows:

 

                                   

(In thousands)

Gain (Loss)

   Three Months Ended  
     May 2,
2014
     April 26,
2013
 

     Forward foreign currency contracts

   $                   1,287       $ (2,128

     Forward foreign currency contracts - reclassified from AOCI

     (2,242      (541

     Embedded derivatives

     (1,718                          773   

     Revaluation of monetary assets/liabilities

     (1,494      73   
  

 

 

    

 

 

 

     Total

   $ (4,167    $ (1,823
  

 

 

    

 

 

 

Six Month Period Ended May 2, 2014, Compared with Six Month Period Ended April 26, 2013

Sales for the first six months increased 8.0% over the prior-year period. Sales by segment were as follows:

 

                                                     

(In thousands)

   Incr./(Decr.)
from prior
    year period    
   Six Months Ended  
      May 2,
2014
       April 26,
2013
 

     Avionics & Controls

     8.0%    $     396,040         $     366,700   

     Sensors & Systems

   14.1%      397,823           348,774   

     Advanced Materials

     (0.6)%      240,691           242,050   
     

 

 

      

 

 

 

     Total Net Sales

      $             1,034,554         $              957,524   
     

 

 

      

 

 

 

The 8.0% increase in sales of Avionics & Controls reflected increased sales volumes of interface technologies of $21 million and avionics systems and control and communication systems of $8 million. The $21 million increase in interface technologies sales mainly reflected incremental sales from the Gamesman acquisition. A $4 million increase in avionics systems mainly reflected higher sales of aviation products for defense applications. A $5 million increase in control and communication systems sales mainly reflected increased sales volumes of control panels and switches of $6 million for commercial aviation applications. Additionally, the increase reflected higher sales volumes of communication systems to enhance security and aural clarity in military communications and secure communication devices of $7 million. These increases were partially offset by reduced sales of cockpit controls of $6 million and embedded communication intercept receivers of $3 million for defense applications.

The 14.1% increase in sales of Sensors & Systems principally reflected increased sales of connection technologies of $34 million and power systems of $10 million. The increase in connection technologies reflected incremental sales from the Sunbank acquisition of $14 million and higher sales volumes of connection technologies for

 

31


commercial aviation and industrial applications. The increase in power systems sales mainly reflected higher OEM sales for commercial aviation applications. Advanced sensors sales increased $6 million on improved OEM sales partially offset by lower aftermarket sales. Segment sales also benefited from a stronger euro and U.K. pound relative to the U.S. dollar compared with the prior-year period.

The 0.6% decrease in sales of Advanced Materials principally reflected lower sales volumes of defense technologies of $17 million, substantially offset by increased sales of engineered materials for defense and commercial aviation applications.

Overall, gross margin as a percentage of sales was 34.4% and 35.7% for the first six months of fiscal 2014 and 2013, respectively. Gross profit was $355.6 million and $341.7 million for the first six months of fiscal 2014 and 2013, respectively. Gross margin was impacted by $2.1 million in restructuring expense in the first six months of fiscal 2014.

Avionics & Controls segment gross margin was 36.4% and 36.7% for the first six months of fiscal 2014 and 2013, respectively. Segment gross profit was $144.2 million compared to $134.7 million in the prior-year period, reflecting a $16 million increase on gross profit from sales of avionics systems and interface technologies, partially offset by a $6 million decrease on gross profit on sales of control and communication systems. Gross profit on avionics systems increased $10 million mainly due to higher sales of aviation products for defense applications. Gross profit on interface technologies increased $6 million mainly due to incremental sales from the Gamesman acquisition. The decrease in gross profit on control and communication systems was due to lower demand for cockpit control devices and embedded communication intercept receivers.

Sensors & Systems segment gross margin was 33.7% and 37.4% for the first six months of fiscal 2014 and 2013, respectively. Segment gross profit was $134.0 million compared to $130.3 million in the prior-year period. The increase in gross profit was mainly due to higher sales volumes of connection technologies. The decrease in gross margin reflected lower aftermarket sales of advanced sensors and power systems and higher operating expenses at our advanced sensor operations.

Advanced Materials segment gross margin was 32.2% for the first six months of fiscal 2014 compared to 31.7% for the same period one year ago. Segment gross profit was $77.4 million compared to $76.8 million in the prior-year period. The slight increase in segment gross profit reflected a $9 million increase in gross profit on higher sales of elastomer materials for commercial aviation and defense applications, partially offset by a decrease in gross profit on sales of defense technologies due to lower sales of combustible ordnance and flare countermeasures.

Selling, general and administrative expenses (which include corporate expenses) totaled $194.7 million, or 18.8% of sales, and $196.9 million, or 20.6% of sales, for the first six months of fiscal 2014 and 2013, respectively. The decrease in selling, general and administrative expense as a percentage of sales mainly reflected higher sales volumes.

Research, development and engineering spending was $53.3 million, or 5.2% of sales, for the first six months of fiscal 2014 compared with $48.7 million, or 5.1% of sales, for the first six months of fiscal 2013. The increase in research, development and engineering spending principally reflects higher spending on avionics systems and advanced sensors. Fiscal 2014 research, development and engineering spending is expected to be in the range of approximately 5% to 5.25% of sales.

Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the first six months of fiscal 2014 totaled $133.0 million, or 12.9% of sales, compared with $128.5 million, or 13.4% of sales, for the first six months in fiscal 2013. Excluding restructuring expenses of $8.7 million, segment earnings were $141.8 million, or 13.7% of sales, for the first six months of 2014.

Avionics & Controls segment earnings were $46.3 million, or 11.7% of sales, in the first six months of fiscal 2014 and $40.1 million, or 10.9% of sales, in the first six months of fiscal 2013, mainly reflecting a $7 million increase in avionics systems and a $4 million increase in interface technologies, partially offset by a $5 million decrease in control and communication systems. Avionics systems earnings benefited from increased gross profit, partially offset by $3.1 million in restructuring expense, mainly severance, and higher research, development and engineering

 

32


expense of $2 million. The increase in interface technologies earnings reflected incremental earnings from the Gamesman acquisition. Control and communication systems earnings were mainly impacted by decreased earnings on lower sales of cockpit control devices and embedded communication intercept receivers.

Sensors & Systems segment earnings were $43.3 million, or 10.9% of sales, for the first six months of fiscal 2014 compared with $42.2 million, or 12.1% of sales, for the first six months of fiscal 2013. Sensors & Systems benefited by improved earnings from increased sales of connection technologies, partially offset by lower earnings on sales of advanced sensors and $2.2 million in segment restructuring expense.

Advanced Materials segment earnings were $43.4 million, or 18.0% of sales, for the first six months of fiscal 2014 compared with $46.3 million, or 19.1% of sales, for the first six months of fiscal 2013, primarily reflecting lower earnings from sales of combustible ordnance and countermeasures and restructuring expense of $3.1 million. The restructuring expense mainly reflected a loss from the write off of certain property, plant and equipment resulting from a planned facility closure. This decrease in segment earnings was partially offset by increased gross profit on higher sales of elastomer materials for commercial aviation and defense applications.

Interest expense for the first six months of fiscal 2014 was $17.1 million compared with $21.9 million for the first six months of fiscal 2013, reflecting lower borrowings.

The income tax rate was 19.4% and 16.2% for the first six months of fiscal 2014 and 2013, respectively. In the first six months of 2014, we recognized approximately $1.1 million of discrete tax benefits principally related to the following items: first was approximately $0.6 million of tax benefits due to the release of reserves due to the expiration of a statute of limitations; second was a $0.5 million reduction of net deferred income tax liabilities as a result of the enactment of tax laws reducing the U.K. statutory income tax rate. In the first six months of 2013, we recognized $3.6 million of discrete tax benefits principally related to the following items: first item was approximately $1.5 million of tax benefits due to the retroactive extension of the U.S. federal research and experimentation credits; second was approximately $2.3 million of tax benefits related to the settlement of U.S. and foreign tax examinations. The income tax rate differed from the statutory rate in the first six months of fiscal 2014 and 2013, as both years benefited from various tax credits and certain foreign interest expense deductions.

It is reasonably possible that within the next twelve months approximately $1.6 million of tax benefits that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of a statute of limitations.

To the extent that sales are transacted in a currency other than the functional currency of the operating unit, we are subject to foreign currency fluctuation risk.

We use forward contracts to hedge our foreign currency exchange risk. To the extent that these contracts qualify as hedges under U.S. GAAP, the amount of gain or loss is deferred in AOCI until the related sale occurs. Also, we are subject to foreign currency gains or losses from embedded derivatives on backlog denominated in a currency other than the functional currency of our operating companies or its customers. Gains and losses on forward contracts, embedded derivatives, and revaluation of assets and liabilities denominated in a currency other than the functional currency of the Company for the six month periods ended May 2, 2014, and April 26, 2013, are as follows:

 

33


(In thousands)

Gain (Loss)

   Six Months Ended  
     May 2,
2014
     April 26,
2013
 

     Forward foreign currency contracts

   $ 793       $ (1,758

     Forward foreign currency contracts reclassified from AOCI

     (2,741      (631

     Embedded derivatives

                         805                         1,270   

     Revaluation of monetary assets/liabilities

     (157      (2,394
  

 

 

    

 

 

 

     Total

   $ (1,300    $ (3,513
  

 

 

    

 

 

 

New orders for the first six months of fiscal 2014 were $1.1 billion compared with $967.7 million for the same period in 2013. Backlog was $1.3 billion at May 2, 2014, April 26, 2013, and at October 25, 2013.

Liquidity and Capital Resources

Cash and cash equivalents at May 2, 2014, totaled $207.4 million, an increase of $28.3 million from October 25, 2013. Net working capital increased to $750.7 million at May 2, 2014, from $683.6 million at October 25, 2013. Sources and uses of cash flows from operating activities principally consist of cash received from the sale of products and cash payments for material, labor and operating expenses. Cash flows provided by operating activities were $84.5 million and $122.7 million in the first six months of fiscal 2014 and 2013, respectively, reflecting an increase in working capital, particularly inventory.

Cash flows used by investing activities were $65.3 million and $65.1 million in the first six months of fiscal 2014 and 2013, respectively. Cash flows used by investing activities in the first six months of fiscal 2014 primarily reflected cash paid for capital expenditures of $21.3 million and acquisitions of $44.0 million. Cash flows used by investing activities in the first six months of fiscal 2013 primarily reflected cash paid for capital expenditures and acquisitions.

Cash flows provided by financing activities were $8.2 million in the first six months of fiscal 2014. Cash flows used by financing activities in the first six months of fiscal 2013 were $46.9 million. Cash flows provided by financing activities in the first six months of fiscal 2014 primarily reflected $23.0 million from issuance of common stock under our employee stock plans and $25.0 million of proceeds from issuance of long-term credit facilities, which were partially offset by repayment of long-term debt and credit facilities of $44.3 million. Cash flows used by financing activities in the first six months of fiscal 2013 primarily reflected repayment of long-term debt and credit facilities for $237.5 million and proceeds from our long-term credit facilities of $175.0 million.

We believe cash on hand and funds generated from operations are adequate to service operating cash requirements and capital expenditures through the next twelve months.

Capital expenditures, consisting of machinery, equipment and computers, are anticipated to be approximately $60 million during fiscal 2014, compared with $55.3 million expended in fiscal 2013 (excluding acquisitions).

Total debt at May 2, 2014, was $667.2 million and consisted of the $250.0 million 7.0% Senior Notes due August 2020, $166.3 million of the $175.0 million term loan, $12.5 million (€9.0 million) of the €125.0 million term loan, $130.0 million in borrowings under our secured credit facility, $52.1 million of government refundable advances, $56.0 million under capital lease obligations and $0.3 million under our various foreign currency debt agreements and other debt agreements.

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should” or “will” or the negative of such terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risk factors set forth in “Forward-Looking Statements” and “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 25, 2013, that may cause our or the industry’s actual results, performance or achievements to be

 

34


materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included or incorporated by reference into this report are made only as of the date hereof. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.

Item 3.             Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in our exposure to market risk during the first six months of fiscal 2014. A discussion of our exposure to market risk is provided in the Company’s Annual Report on Form 10-K for the fiscal year ended October 25, 2013.

Item 4.             Controls and Procedures

Our principal executive and financial officers evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of May 2, 2014. Based upon that evaluation, they concluded as of May 2, 2014, that our disclosure controls and procedures were effective to ensure that information we are required to disclose in the reports that we file under the Exchange Act is recorded, processed, summarized and reported within time periods specified in Securities and Exchange Commission rules and forms. In addition, our principal executive and financial officers concluded as of May 2, 2014, that our disclosure controls and procedures are also effective to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including to our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

During the time period covered by this report, there were no significant changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

35


PART II – OTHER INFORMATION

Item 1.             Legal Proceedings

From time to time we are involved in legal proceedings arising in the ordinary course of business. We believe that adequate reserves for these liabilities have been made and that there is no litigation pending that could have a material adverse effect on our results of operations and financial condition.

See Note 15 to the consolidated financial statements included in Part 1, Item 1 of this report for information regarding legal proceedings.

Item 6.             Exhibits

     10.1      Consent Agreement between Esterline Technologies Corporation and the U.S. Department of State Bureau of Political Military Affairs dated March 5, 2014. (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated March 5, 2014 [Commission File No. 1-6357].)
     11      Schedule setting forth computation of basic and diluted earnings per common share for the three and six month periods ended May 2, 2014, and April 26, 2013.
     31.1      Certification of Chief Executive Officer.
     31.2      Certification of Chief Financial Officer.
     32.1      Certification (of Curtis C. Reusser) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     32.2      Certification (of Robert D. George) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   101.INS      XBRL Instance Document
   101.SCH      XBRL Taxonomy Extension Schema
   101.CAL      XBRL Taxonomy Extension Calculation Linkbase
   101.DEF      XBRL Taxonomy Extension Definition Linkbase
   101.LAB      XBRL Taxonomy Extension Label Linkbase
   101.PRE      XBRL Taxonomy Extension Presentation Linkbase

 

36


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ESTERLINE TECHNOLOGIES CORPORATION  
                                   (Registrant)  
Dated:  June 5, 2014   By:    

/s/ Robert D. George

 
    Robert D. George  
    Chief Financial Officer, Vice President,  
    and Corporate Development  
    (Principal Financial Officer)  

 

37